Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fabien Hernandez"'
Autor:
Fabien Hernandez, Elyes Majoul, Carlota Montes-Palacios, Marie Antignac, Bertrand Cherrier, Levon Doursounian, Jean-Marc Feron, Cyrille Robert, Gilles Hejblum, Christine Fernandez, Patrick Hindlet
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0134101 (2015)
To assess the impact of the implementation of a Computerized Physician Order Entry (CPOE) associated with a pharmaceutical checking of medication orders on medication errors in the 3 stages of drug management (i.e. prescription, dispensing and admini
Externí odkaz:
https://doaj.org/article/bc4b26206c344cf09c262c771dba3602
Autor:
B. Cassard, C. Flateau, Fabien Hernandez, Pierre Danneels, Sylvain Diamantis, Nabil Belfeki, M. Picque, C. Chakvetadze, Astrid de Pontfarcy, Alessio Strazzulla
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 38:177-183
In 2017, five cases of severe haemorrhages during treatment with cefazolin occurred in France. The aim of this study was to assess the risk of haemorrhage related to treatment with cefazolin by evaluating haemostatic parameters and bleeding events. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::323cf6d00fa3128a7689aeb95a66e798
https://doi.org/10.1007/s10096-018-3412-6
https://doi.org/10.1007/s10096-018-3412-6
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 51:361-362
Introduction Le palivizumab (Synagis®) est une molecule onereuse (461 € le flacon de 50 mg et 765,63 € le flacon de 100 mg), dont la prescription en milligramme par kilo, chez les nouveau-nes et les nourrissons, entraine regulierement des pertes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4c7e5572e0e0560e907649191bd1dd5
https://doi.org/10.1016/j.phclin.2016.10.049
https://doi.org/10.1016/j.phclin.2016.10.049